BioCatalyst

LGVN — Longeveron Inc. catalysts

1 verified catalyst event(s) for Longeveron Inc. (ticker LGVN). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-06-30 — Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS) · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-30
in 8d
ESTIMATED
 READOUT
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndr
Phase 2 · Hypoplastic Left Heart Syndrome
 LGVN Longeveron Inc. Lomecel-B medicinal signaling cells ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.